With multiple companies creating a vaccine in record time, the COVID-19 pandemic has spotlighted the role pharmaceuticals and regulatory agencies play in combating an unseen opponent. Our reliance on a healthy pharmaceutical industry is nothing new, and questions of how to regulate pharmaceutical products, including their prices, have long been the subject of debate. Recently, … Continue reading “Symposium on the Economics and Law of Pharmaceutical Regulation: Emerging Issues”